GLP Watchdog

Embody vs GoodRx

Neither Embody nor GoodRx has an FDA warning letter on record. No price lines up like for like: Embody and GoodRx publish prices for different products.

To see where both sit among the other sellers, read our best weight-loss injection providers board.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

Embody / GoodRx

Featured pick (affiliate partner)

Embody logo

Embody

9.3/10

GoodRx logo

GoodRx

7.8/10

FDA warning letters
None on record
None on record
Pharmacy
Brand-name only; no compounding
Lowest standing price
$79/moCompounded semaglutide injection
$149/moFoundayo (orforglipron) pill
States
All 50 states and DC
48 states
Checked
Prices captured Record checked October 2026
Prices captured Record checked October 2026
Visit Embody
Visit GoodRx

Embody is our featured pick on this page because it is an affiliate partner: we are paid if you sign up through our link. GoodRx pays us nothing. The scores are computed the same way for both and are shown as computed (Embody 9.3, GoodRx 7.8). How we are paid

What the record shows

  1. 01

    Neither Embody nor GoodRx has an FDA warning letter on record.

  2. 02

    Embody names four pharmacies. GoodRx sells brand-name medication only.

  3. 03

    No price lines up like for like: Embody and GoodRx publish prices for different products.

  4. 04

    Only Embody lists a price for compounded semaglutide injection, compounded tirzepatide injection and compounded oral tirzepatide. Only GoodRx lists a price for brand-name tirzepatide pen and Foundayo (orforglipron) pill.

  5. 05

    Embody covers two states GoodRx does not.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

Embody

GoodRx

Compounded semaglutide injection

$79/mo

$948 a year

Not sold or not priced
Compounded tirzepatide injection

$129/mo

$1,548 a year

Not sold or not priced
Brand-name tirzepatide pen
Not sold or not priced

$299/mo

$3,588 a year

Compounded oral tirzepatide

$329/mo

$3,948 a year

Not sold or not priced
Foundayo (orforglipron) pill
Not sold or not priced

$149/mo

$1,788 a year

Price includes
Medication, clinician visits, shipping
Not stated
Cancel any time
Yes, stated
Yes, stated
Minimum term
None on the one-month plan; 3-, 6- and 12-month plans are prepaid
None
Refunds
No refunds once paid; a partial refund only after a medical disqualification
Services and medication are generally non-refundable
Early-exit fee
None stated
Not stated

Read off each seller’s own pages. Embody: October 30, 2026. GoodRx: October 30, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for Embody

9.3/10
Featured pick (affiliate partner)
  • Sells compounded semaglutide injection and compounded tirzepatide injection, which GoodRx does not price
Visit Embody

The case for GoodRx

7.8/10
  • Sells brand-name tirzepatide pen and Foundayo (orforglipron) pill, which Embody does not price
Visit GoodRx

Scores

Embody 9.3 · GoodRx 7.8 out of 10. Six weighted parts.

Value25%

10.0A
vs
B
8.7

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
5.0

Trust & Safety15%

9.0A
vs
B
6.0

Accessibility10%

10.0A
vs
B
9.7

Support10%

7.0A
vs
B
5.0

The score is the same formula for every seller. Payment does not enter it. Method

Embody vs GoodRx: questions

Neither Embody nor GoodRx has an FDA warning letter on record. Letters are matched to a seller by company, domain and address, never by a similar name.
Embody names four pharmacies. GoodRx sells brand-name medication only. A 503A pharmacy compounds for named patients on a prescription; a 503B outsourcing facility is registered with FDA and inspected under federal manufacturing rules.
No price lines up like for like: Embody and GoodRx publish prices for different products. We only set two prices against each other when they are for the same product and both are standing month-to-month or 4-week rates.
Embody states you can cancel at any time; refunds: no refunds once paid; a partial refund only after a medical disqualification. GoodRx states you can cancel at any time; refunds: services and medication are generally non-refundable.
Embody is our featured pick on this page because it is an affiliate partner: we are paid if you sign up through our link. GoodRx pays us nothing. The scores are computed the same way for both and are shown as computed (Embody 9.3, GoodRx 7.8).

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Sellers closest to these two

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks